Clinical Trials Logo

Ovarian Reserve clinical trials

View clinical trials related to Ovarian Reserve.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05567731 Completed - Infertility Clinical Trials

Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve

Start date: October 15, 2022
Phase: N/A
Study type: Interventional

This study aimed to compare the gonadotropin-releasing hormone agonist (ultra-short) protocol versus (short and long) protocols on ovarian reserve in women undergoing intracytoplasmic sperm injection

NCT ID: NCT05562479 Completed - Clinical trials for SARS-CoV-2 Infection

Effect of Sars-cov-2 on Donor Oocyte Quality and Quantity, a Multicenter Retrospective Study.

Start date: December 12, 2021
Phase:
Study type: Observational

Purpose: To determine the impact of SARS-CoV-2 infection and immunization on ovarian response to controlled ovarian stimulation (COS) and embryo development after in vitro fertilization (IVF) Methods: A retrospective multicentric cohort study of 427 oocyte donors was conducted between January 1st, 2018 and September 18th, 2022. Patients who recovered from SARS-CoV-2 infection, vaccinated or non-exposed were included. Demographic, cycle characteristics, and laboratory outcomes were compared.

NCT ID: NCT04762615 Completed - Immunosuppression Clinical Trials

Impact of Underlying Renal Disease and Immunosuppressive Regimen on Ovarian Reserve in Renal Patients

Start date: June 1, 2018
Phase:
Study type: Observational [Patient Registry]

Aging, renal pathology (eg SLE, ADPKD), X-ray exposition and pharmacological treatments, especially previous strong immunosuppression, may negatively influence the ovarian reserve in childbearing age women. Anti-Müllerian hormone (AMH) is regarded as biomarker for ovarian reserve. Every female with renal disease regularly menstruating that met exclusion criteria could have participated. The aim was to assess ovarian reserve in female patients with normal menstrual cycle and kidney disease, including kidney transplant recipients.

NCT ID: NCT04643925 Completed - Infertility, Female Clinical Trials

hCG Priming in Women With Low Ovarian Reserve

Start date: December 27, 2020
Phase: Phase 4
Study type: Interventional

The aim of this trial is to examine the possible effects of hCG administration for eight weeks prior to IVF/ICSI in women with low ovarian reserve. Primary outcome is the proportion of the antral follicle count that reach the pre-ovulatory stage.

NCT ID: NCT04058678 Completed - Ovarian Reserve Clinical Trials

Effects of Telomerase Reactivation With Danazol in Ovarian Function.

Start date: January 30, 2020
Phase: N/A
Study type: Interventional

This project explores the implication of the telomere pathway in ovarian premature and regular aging. Telomere length and maintenance underlie several biological processes such cancer, aging, human diseases and the biology of stem cells. The reactivation of telomerase should lead to a rejuvenation of the ovarian tissue and the improvement of fertility. The correlation of telomeric factors in blood and granulosa cells will be studied with the aim of finding telomeric biomarkers of ovarian aging.

NCT ID: NCT03989921 Completed - IVF Clinical Trials

Ovarian Reserve and Embryo Implantation

IRO
Start date: November 29, 2018
Phase:
Study type: Observational

Compare, in young patients with In vitro fertilization (IVF), the rate of embryo implantation by early culture transfer (J2-J3) between 2 groups of patients: "normo responders" vs. "poor responders".

NCT ID: NCT03896243 Completed - Ovarian Reserve Clinical Trials

Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation

Start date: January 1, 2018
Phase:
Study type: Observational

Investigators would like to see the amh values after uterine artery ligation

NCT ID: NCT03621683 Completed - Ovarian Reserve Clinical Trials

Antioxidants vs. Ovarian Bio-stimulation Therapy to Rescue the Ovarian Reserve

Start date: January 6, 2016
Phase: N/A
Study type: Interventional

Two group of patients were selected. Group 1 represents 46 patients that received ovarian-biostimulation monthly for three months. Group 2 represents 32 patients that received antioxidant therapy daily for 3 months. Results are noted and analysed. Both groups represent patients with procedures already ongoing, and with diagnosed poor or depleted ovarian reserve. The analysis has been made to compare the efficacy of both procedures.

NCT ID: NCT03492632 Completed - Psoriasis Clinical Trials

Ovarian Reserve in Patients With Psoriasis

Start date: October 25, 2017
Phase:
Study type: Observational

Psoriasis is a common autoimmune disease. It affects women of all ages including reproductive years. Autoimmune diseases including psoriasis are linked to premature ovarian reserve. This study aims to measure serum hormones including FSH,LH,E2,PRL and AMH (indicators of ovarian reserve) in women with and without psoriasis.

NCT ID: NCT02009228 Completed - Abdominal Pain Clinical Trials

Single-port LC Might be Preferable for Managing Ovarian Dermoid Cyst.

Start date: June 2011
Phase: Phase 3
Study type: Interventional

Minimally invasive surgery has become the standard treatment for many gynecologic disease processes. In the last decade, numerous studies have demonstrated that laparoscopic approaches to various gynecologic oncology conditions-particularly for early-stage endometrial and cervical cancers as well as select pelvic masses-is feasible and results in shorter hospital stays, improved quality of life and comparable surgical and oncologic outcomes to abdominal staging.For instance, the typical gynecologic robotic surgical procedure will require Two to three 5-mm ports and one 12-mm laparoscopic ports. Recently, an even less invasive alternative to conventional laparoscopy surgery has been developed: laparoendoscopic single-site surgery (LESS), also known as single-port surgery. Single port laparoscopy is an attempt to further enhance the cosmetic benefits of minimally invasive surgery while minimizing the potential morbidity associated with multiple incisions. Preliminary advances in LESS as applied to urologic and gastrointestinal surgery demonstrate that the techniques are feasible provided that both optimal surgical technical expertise with advanced skills and optimal instrumentation are available. Recently, several publication showed the single port laparoscopic surgery is feasibility in gynecologic surgery including oophorectomy, cystecomty, and myomecomty. To our knowledge, the sample size of recent publication about single port surgery including cystectomy and myomecomty is small. Furthermore, these studies lack the comparison of single port and convectional laparoscopic surgery. Base on our recent study demonstrated that either the single-port or the conventional approach can be used for LAVH, but the single-port LAVH technique yielded less postoperative pain (Chen et al., Obestet Gynecol, 2011). The purpose of this study was to assess the feasibility of single port laparoscopic surgery in the treatment of benign gynecologic disease.